Rhinitis, Allergic: all 1,042 studies
Page 10 of 11. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- Phase 2 Study in Adults Sensitized to Short RagweedWithdrawnNCT00670384Phase 2
- To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)CompletedNCT00659841Phase 3
- To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)CompletedNCT00659750Phase 3
- Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)CompletedNCT00659594Phase 3
- Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)CompletedNCT00659503Phase 3
- Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)CompletedNCT00659048Phase 3
- To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)CompletedNCT00658918Phase 3
- New Nasal Applicator / New Formulation - User StudyCompletedNCT00641979Phase 2
- Assess the Efficacy and Safety of Rhinocort AquaCompletedNCT00641693Phase 2
- Rhinocort Aqua Versus Placebo and Fluticasone PropionateCompletedNCT00641680Phase 3
- Children, Perennial Allergic Rhinitis (PAR), l-t GrowthCompletedNCT00641212Phase 4
- Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic RhinitisCompletedNCT00639587Phase 3
- The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic RhinitisCompletedNCT00638755Phase 2
- Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal AllergenCompletedNCT00638118Phase 4
- A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy SymptomsCompletedNCT00637884Phase 4
- Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure UnitCompletedNCT00637611Phase 4
- Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by HistamineCompletedNCT00637585Phase 4
- Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight PersonnelCompletedNCT00637455Phase 4
- Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for DesloratadineCompletedNCT00636870Phase 4
- CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic RhinitisStatus unknownNCT00631254Not applicable
- Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild AsthmaTerminatedNCT00630461Phase 1
- Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic SubjectsCompletedNCT00620230Phase 1
- Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without AllergiesCompletedNCT00617110Not applicable
- A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNCT00612820Phase 2
- A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic RhinitisCompletedNCT00612118Phase 2
- Acupuncture for Seasonal Allergic RhinitisCompletedNCT00610584Not applicable
- Investigation Of a New Oral Anti-Histamine in Healthy Male SubjectsCompletedNCT00605852Phase 1
- A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in AdultsCompletedNCT00604123Phase 2
- Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional StudyCompletedNCT00598780
- An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated HayfeverCompletedNCT00584584Phase 2
- Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma SeverityTerminatedNCT00584051
- Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SARCompletedNCT00574379Phase 2
- PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)CompletedNCT00574210Phase 2
- Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic DiseaseCompletedNCT00569361Not applicable
- Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)CompletedNCT00564421Phase 3
- A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic RhinitisCompletedNCT00561717Phase 4
- Montelukast as a Controller of Atopic SyndromeCompletedNCT00559546Phase 4
- Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersTerminatedNCT00557895
- Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive SubjectsCompletedNCT00544388Phase 3
- Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic RhinitisCompletedNCT00542607Phase 4
- An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure ChamberCompletedNCT00537355Phase 2
- Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic RhinitisCompletedNCT00533637Phase 2
- To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic RhinitisCompletedNCT00525278Phase 3
- Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic RhinitisCompletedNCT00524836Phase 3
- Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust MitesCompletedNCT00521131Phase 4
- Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SARCompletedNCT00521040Not applicable
- A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.CompletedNCT00517946
- Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway SensitivityCompletedNCT00513487Not applicable
- Efficacy Study for the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00504933Phase 3
- Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum PratenseCompletedNCT00501527Phase 2
- Cetirizine Placebo Controlled Study For Perennial Allergic RhinitisCompletedNCT00490204Phase 3
- Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic RhinitisStatus unknownNCT00488176Phase 4
- Differential Adrenoreceptor Mediated Tachyphylaxis and UpregulationCompletedNCT00487032Phase 4
- Effect of a Nasal Bolus Allergen Challenge on Inflammatory MarkersCompletedNCT00483353Phase 1
- The Anti-allergic Effects of Specific ProbioticsCompletedNCT00480129Phase 1
- Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of SeasonCompletedNCT00474890Not applicable
- Intranasal Steroids and the Nasal Ocular ResponseCompletedNCT00473915Phase 4
- Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol SupplementsCompletedNCT00466596Phase 1
- Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis SymptomsCompletedNCT00460538Phase 4
- MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)CompletedNCT00446186Phase 2
- Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic RhinitisCompletedNCT00443495Phase 1/2
- Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic RhinitisCompletedNCT00439712Phase 4
- Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00430157Phase 2
- Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass PollenCompletedNCT00426179Phase 1/2
- Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)CompletedNCT00423995Phase 3
- Twin SUBLIVAC® Grasses Clinical Efficacy StudyCompletedNCT00422149Phase 3
- A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge ChamberCompletedNCT00420082Phase 2
- A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of BilastineCompletedNCT00419783Phase 1
- A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic RhinitisCompletedNCT00407927Phase 2
- Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory InfectionsCompletedNCT00405899
- Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental ChamberCompletedNCT00404586Phase 1
- Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic RhinitisCompletedNCT00400998Phase 2
- To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)CompletedNCT00398151Phase 3
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1CompletedNCT00396149Phase 1
- Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic AdultsTerminatedNCT00387738Phase 2
- Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic RhinitisTerminatedNCT00387478Phase 2
- Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or PlaceboWithdrawnNCT00385463Not applicable
- A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)CompletedNCT00384475Phase 3
- Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)CompletedNCT00380705Phase 4
- Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00377728Phase 2
- A Trial of Point of Care Information in Ambulatory PediatricsCompletedNCT00368823Phase 3
- Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 YearsCompletedNCT00365469Phase 2
- Study of GW685698X In Patients With Seasonal Allergic RhinitisCompletedNCT00363740Phase 3
- Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine MetabolismCompletedNCT00362999
- Study Of Perennial Allergic RhinitisCompletedNCT00358475Phase 3
- Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic RhinitisCompletedNCT00355771Phase 4
- Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)CompletedNCT00348361Phase 1
- DNA Vaccine for Ragweed Allergic AdultsCompletedNCT00346086Phase 2
- Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic RhinitisCompletedNCT00334698Not applicable
- Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic RhinitisCompletedNCT00325338Phase 2
- Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal PeriodCompletedNCT00325273Phase 3
- Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)CompletedNCT00319995Phase 3
- Treatment of Ragweed-Allergic Asthma With an Immunostimulatory DrugTerminatedNCT00318747Phase 2
- Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological ResponsesCompletedNCT00318695Phase 2
- Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed PollenCompletedNCT00315523Phase 3
- Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen OxideStatus unknownNCT00312312Not applicable
- Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)CompletedNCT00305487Phase 3
- Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008Status unknownNCT00298337Phase 2/3
- A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal SecretionsCompletedNCT00297843
- Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4